Linguamatics has joined the Microsoft BioIT Alliance, an association of life science organisations and informatics companies whose focus is to enhance collaboration and accelerate the pace of drug discovery and development.
‘As the amount of textual information impacting drug discovery and development programs grows exponentially each year, the ability to extract and share decision-relevant knowledge is crucial to streamline the process and raise productivity,’ said Roger Hale, COO and co-founder of Linguamatics.
The BioIT Alliance is designed to enable collaboration among organisations in the life sciences field in order to shorten the time between discovery of new biological data and the application of that knowledge to human health.
